2026 NPPES data Hematology & Oncology Physician NPI 1881896157 M.D.
Verify on CMS →

Megan Baumgart, M.D.

Hematology & Oncology Physician in Rochester, New York.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
294
Medicare Part D claims · 91 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.8/100
▼ 6 pts below national avg 83.1 · Above neutral
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Megan Baumgart, M.D. reported a CMS MIPS final score of 76.8/100 - below the 83.1 national average - and filed 294 Medicare Part D claims in 2023.

76.8/100
MIPS score · -6 vs avg
294
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Megan Baumgart, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

77 21st percentile higher than 21% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Megan Baumgart, M.D. sits

This provider among hematology & oncology physician peers

Across the 4,233 hematology & oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Megan Baumgart, M.D. writes more Part D claims than 23% of them and scores higher on MIPS quality than 22% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100024.148.372.496.6Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 65Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 25Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 62Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 73Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 27Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 82Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 17Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 18Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 30Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 45Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 85Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 22Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 20Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 33Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 92Megan Baumgart, M.D.-Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 22
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one hematology & oncology physician peer from a representative sample of 60; the gold marker is Megan Baumgart, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Megan Baumgart, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Megan Baumgart, M.D.?

Below national average

NPI registry status

Active

Issued 05/31/2007

NPI 1881896157

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

294 65% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

76.8/100 6.3 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in New York

How Hematology & Oncology Physician compares to other specialties among New York providers

New York providers
Student in an Organized Health Care Education/Training Program - 7.8%Student in an Organized Health Care Education/Training Program7.8%Registered Nurse - 5.2%Registered Nurse5.2%Clinical Social Worker - 4.9%Clinical Social Worker4.9%Social Worker - 4.5%Social Worker4.5%Speech-Language Pathologist - 4.5%Speech-Language Pathologist4.5%Licensed Practical Nurse - 4.3%Licensed Practical Nurse4.3%Hematology & Oncology Physician - 0.2%Hematology & Oncology Physician0.2%
Largest specialties in New York (% of in-state providers)

Medicare quality performance, MIPS

Megan Baumgart, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
76.8/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) - 76.8/100 vs national avg 83.1

0%100%National avg83%76.8%
MIPS final score (Hematology & Oncology Physician) - 76.8/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Megan Baumgart, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 601 ELMWOOD AVE, Rochester, NY, 14642, with a listed phone of (585) 275-5863. NPI 1881896157 was issued on 05/31/2007.

Medicare Part D records for calendar year 2023 show 294 prescription claims written by this provider, covering 91 Medicare beneficiaries and totaling roughly $267K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 11.9%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.8/100 for the 2023 performance year (Quality 68.2, Cost 42.7), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

601 ELMWOOD AVE
Rochester, NY 14642

Provider Details

NPI 1881896157
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 05/31/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

76.8466
Final Score
Avg: 83.1
68.2024
Quality
42.684
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where Megan Baumgart, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Hematology Clinical Group
Rochester, NY
University OF Rochester
Rochester, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - New York NYSBPMC 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Megan Baumgart, M.D.. To verify Megan Baumgart, M.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Megan Baumgart, M.D. - brand share 10.0%
Hematology & Oncology Physician average

10% brand-name claims vs 90% generic, on 294 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

294
Total Claims
$267K
Total Drug Cost
91
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
312
Total Day Supply
5,136
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$196K
Generic Drug Cost
$71K
Opioid Claims
35 (11.9% rate)
Antibiotic Claims
24

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
2.59
Gender Split
51% female / 49% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Megan Baumgart, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prochlorperazine Maleate
56
Ondansetron Hcl
46
Oxycodone Hcl
21
Pantoprazole Sodium
18
Levothyroxine Sodium
16
Prednisone
16
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
14
Lorazepam
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Megan Baumgart, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

Megan Baumgart, M.D.'s 294 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Baumgart.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Megan Baumgart, M.D.'s specialty?
Megan Baumgart, M.D. specializes in Hematology & Oncology Physician and practices in Rochester, New York. Credentials: M.D..
How much does Megan Baumgart, M.D. prescribe under Medicare Part D?
In 2023, Megan Baumgart, M.D. wrote 294 Medicare Part D claims totaling $267K in drug costs for 91 beneficiaries.
What is Megan Baumgart, M.D.'s Medicare quality score?
Megan Baumgart, M.D. has a CMS MIPS Final Score of 76.8/100 (Quality: 68.2, Cost: 42.7). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Megan Baumgart, M.D. located?
Megan Baumgart, M.D. is located at 601 ELMWOOD AVE, Rochester, NY, 14642. Phone: (585) 275-5863.
What is Megan Baumgart, M.D.'s NPI number?
Megan Baumgart, M.D.'s National Provider Identifier (NPI) is 1881896157, issued on 05/31/2007.
Does Megan Baumgart, M.D. prescribe more brand-name or generic drugs?
Megan Baumgart, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $196K in brand drug costs.
Does Megan Baumgart, M.D. prescribe opioids?
Yes, Megan Baumgart, M.D. had 35 opioid claims in 2023 with an opioid prescribing rate of 11.9%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Megan Baumgart, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Megan Baumgart, M.D.'s most frequently prescribed drugs include Prochlorperazine Maleate, Ondansetron Hcl, Oxycodone Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Megan Baumgart, M.D. accept Medicare?
Megan Baumgart, M.D. appears in CMS Medicare data with 294 Part D claims and 91 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Megan Baumgart, M.D.'s credentials?
Megan Baumgart, M.D.'s NPI is 1881896157 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.